Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
about
Three-dimensional structure of a transglutaminase: human blood coagulation factor XIIICrystal structure of anti-Hen egg white lysozyme antibody (HyHEL-10) Fv-antigen complex. Local structural changes in the protein antigen and water-mediated interactions of Fv-antigen and light chain-heavy chain interfacesStructural insights into steroid hormone binding: the crystal structure of a recombinant anti-testosterone Fab fragment in free and testosterone-bound formsStructural Characterization of the 1918 Influenza Virus H1N1 NeuraminidaseTrypanosoma cruzi trans-Sialidase in Complex with a Neutralizing Antibody: Structure/Function Studies towards the Rational Design of InhibitorsBound water molecules and conformational stabilization help mediate an antigen-antibody associationRefined structures of bobwhite quail lysozyme uncomplexed and complexed with the HyHEL-5 Fab fragmentReverse Genetics Approaches for the Development of Influenza VaccinesMolecular basis for broad neuraminidase immunity: conserved epitopes in seasonal and pandemic H1N1 as well as H5N1 influenza virusesSnugDock: paratope structural optimization during antibody-antigen docking compensates for errors in antibody homology modelsInfluenza virus neuraminidase (NA): a target for antivirals and vaccines.H5N1 virus-like particle vaccine elicits cross-reactive neutralizing antibodies that preferentially bind to the oligomeric form of influenza virus hemagglutinin in humans.An influenza A virus (H7N9) anti-neuraminidase monoclonal antibody with prophylactic and therapeutic activity in vivo.Actin surface structure revealed by antibody imprints: evaluation of phage-display analysis of anti-actin antibodies.Mimotopes: realization of an unlikely concept.Evolutionary dynamics of N-glycosylation sites of influenza virus hemagglutinin.Interactions of protein antigens with antibodies.Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge.Structure and distribution of modules in extracellular proteins.Activity-modulating monoclonal antibodies to the human serine protease HtrA3 provide novel insights into regulating HtrA proteolytic activities.Antibody epitopes on the neuraminidase of a recent H3N2 influenza virus (A/Memphis/31/98).Structural characterization of a protective epitope spanning A(H1N1)pdm09 influenza virus neuraminidase monomers.Influenza neuraminidase.Contribution of a single heavy chain residue to specificity of an anti-digoxin monoclonal antibody.Molecular requirements for T cell recognition by a major histocompatibility complex class II-restricted T cell receptor: the involvement of the fourth hypervariable loop of the Valpha domain.Antigenicity of the N8 influenza A virus neuraminidase: existence of an epitope at the subunit interface of the neuraminidaseIntramolecular immunological signal hypothesis revived--structural background of signalling revealed by using Congo Red as a specific tool.Electrostatic contributions to protein-protein interactions: fast energetic filters for docking and their physical basisAssessing the performance of the MM/PBSA and MM/GBSA methods. 6. Capability to predict protein-protein binding free energies and re-rank binding poses generated by protein-protein docking.De Novo Sequencing and Resurrection of a Human Astrovirus-Neutralizing Antibody.Molecular and biological constraints on ligand-binding affinity and specificity.Topology characterization of a benzodiazepine-binding beta-rich domain of the GABAA receptor alpha1 subunit.Rapid optimization of a peptide inhibitor of malaria parasite invasion by comprehensive N-methyl scanning.Local and long-range structural effects caused by the removal of the N-terminal polypeptide fragment from immunoglobulin L chain lambda.Comparison of epitope structures of H3HAs through protein modeling of influenza A virus hemagglutinin: mechanism for selection of antigenic variants in the presence of a monoclonal antibody.Structural model of the anti-snake-toxin antibody, M alpha 2,3.
P2860
Q24564521-79A4B73C-6595-434E-91CC-3E9DB4ADF0A5Q27619619-60912636-1455-4A7A-B4A4-76DC4B05E87DQ27636203-C3F432E0-ADF6-4D93-AC5E-88EB116D46EFQ27651719-D33FF0F5-AA09-4B29-920F-F357EB46227CQ27676712-F179FEDB-FADE-4BCF-B766-199912AF5A7DQ27731557-24583481-2A54-4D72-A497-587D74A85C51Q27733724-8C2A28FC-2B39-41A4-B739-5C780FACF882Q28076140-9925EE10-30A4-43CE-B283-7662D605B3ABQ28387782-1A239FE6-6D65-4ACA-BE16-61798053775BQ28472510-FD0A360D-2602-4E20-A084-44DBA556C1C7Q30249879-144A7B1E-2493-40B3-8F9A-0F81FF730129Q30406365-AE78B2D4-723C-4E86-8D63-68715B45ADEBQ30571702-10A39BFD-7C6C-484B-95F7-DD7A5208795FQ30672300-3BD03AD6-A323-45E0-89DF-204168C91F78Q30976506-76B0A02D-2281-451A-8422-E5ACF56DB471Q33520040-22A1D41E-D50F-409B-B0F8-4DACA49C538BQ33594252-F99677AD-BD89-4AD5-B0E3-44EE55011E67Q34057785-5E60A67A-1105-4D3A-8333-E39D5FB95F5FQ34063457-E79201F8-2933-4530-A773-F1C3DE9BE2F1Q34232310-A9398B2F-0B4F-4069-8374-5D8E106D78FBQ34359863-49C136CE-B3B7-4418-BF87-8875A042C251Q35139986-FE156768-B188-4243-A99B-8B7994E7588FQ35791130-EA0E2EA0-C7E9-4E0C-9927-A427A23D77C2Q36278518-D61B9702-88BC-473A-B844-EAA487180429Q36367729-F3E6DC14-A25E-4A80-B83A-CE5B3C8966EDQ36629944-CCB459E5-2CF3-40B2-8A5C-677D8CA16123Q38272021-2BDFB6DD-8F74-4247-B25F-21EBCE377288Q38272342-7900F94A-B2A4-43FE-BCE9-B4255F85E400Q39574481-B247EC04-91E7-4AA2-87B4-81EC2DAB692AQ40663787-8179DEB4-B7CD-437D-B616-5B76FB7564EDQ41630766-DF22BBD6-8733-4B3A-AE26-24ABEA9F5931Q43057875-C3B878BF-26FB-4E6F-830D-1DC1C7F416C5Q43148430-15A6F3D3-AD50-4AA4-8285-B11938982951Q44454044-244E7239-24A1-4644-9541-068E9317838BQ45398522-49AF7E42-C7D4-44F6-8329-9D2E05077428Q52297894-A9A535BA-912B-4380-97B0-0FE9B8031D56
P2860
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
description
1992 nî lūn-bûn
@nan
1992 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1992 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1992年の論文
@ja
1992年学术文章
@wuu
1992年学术文章
@zh-cn
1992年学术文章
@zh-hans
1992年学术文章
@zh-my
1992年学术文章
@zh-sg
1992年學術文章
@yue
name
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@ast
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@en
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@nl
type
label
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@ast
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@en
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@nl
prefLabel
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@ast
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@en
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@nl
P2093
P1476
Refined crystal structure of the influenza virus N9 neuraminidase-NC41 Fab complex
@en
P2093
J N Varghese
P M Colman
P304
P356
10.1016/0022-2836(92)90687-F
P407
P577
1992-09-05T00:00:00Z